Clincosm LogoSign in Get a demo

myelofibrosis

Showing 51 - 75 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

Active, not recruiting
  • Myelofibrosis
  • Antwerpen, Belgium
  • +11 more
Aug 19, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022

Myelofibrosis Trial in Paris (Ruxolotinib)

Completed
  • Myelofibrosis
  • Paris, France
    ROBIN
Jul 26, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

Withdrawn
  • Myelofibrosis
  • Gilbert, Arizona
  • +1 more
Jul 8, 2022

Myelofibrosis Trial in Jinan (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jul 3, 2022

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 7, 2022

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • (no location specified)
Jun 5, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +65 more
Jun 2, 2022

Solid Tumor, Adult, Non-Hodgkin Lymphoma, Adult, NSCLC Trial in Rozzano, Siena, Glasgow (IOA-244, Avelumab Injection,

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Rozzano, Milan, Italy
  • +2 more
May 13, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

Completed
  • Myelofibrosis
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
Mar 28, 2022

Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Recruiting
  • Myelofibrosis
  • Hematopoietic Stem Cell Transplant
  • Minneapolis, Minnesota
    Center for International Blood and Marrow Transplant Research
Mar 17, 2022

Myelofibrosis Trial in Australia (KER-050 monotherapy, KER-050 in combination with ruxolitinib)

Recruiting
  • Myelofibrosis
  • KER-050 monotherapy
  • KER-050 in combination with ruxolitinib
  • Tweed Heads, New South Wales, Australia
  • +4 more
Mar 2, 2022

Myelofibrosis Trial in Canada, United States (itacitinib)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +4 more
Mar 8, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022